Advertisement
Screener

BRISTOL-MYERS SQUIBB COMPANY (BMY) OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax

2.2 / 5 stars · 48/110 Roast Me

BRISTOL-MYERS SQUIBB COMPANY OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax

BRISTOL-MYERS SQUIBB COMPANY (BMY) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax · last filed 2026-07-30

  • BRISTOL-MYERS SQUIBB COMPANY oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2026-06-30 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2026-03-31 was -$1.00M.
  • BRISTOL-MYERS SQUIBB COMPANY oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2025-06-30 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for the quarter ending 2025-03-31 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2022 was $0.00.
  • BRISTOL-MYERS SQUIBB COMPANY oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2021 was -$2.00M, a 300.00% decline from fiscal 2020.
  • BRISTOL-MYERS SQUIBB COMPANY oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2020 was $1.00M, a 88.89% decline from fiscal 2019.
  • BRISTOL-MYERS SQUIBB COMPANY oci, debt securities, available-for-sale, gain (loss), after adjustment, tax for fiscal 2019 was $9.00M.
Period endOCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 3 monthOCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 3 month as first filedOCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 6 monthOCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 9 monthOCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 9 month as first filedOCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 12 monthOCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax 12 month as first filed
2026-06-30$0.00
10-Q · filed 2026-07-30
-$1.00M
10-Q · filed 2026-07-30
2026-03-31-$1.00M
10-Q · filed 2026-04-30
2025-06-30$0.00
10-Q · filed 2026-07-30
$0.00
10-Q · filed 2026-07-30
2025-03-31$0.00
10-Q · filed 2026-04-30
2024-09-30$2.00M
10-Q · filed 2024-10-31
$1.00M
derived: sum of 2 quarters · filed 2024-10-31
$1.00M
10-Q · filed 2024-10-31
2024-06-30-$1.00M
10-Q · filed 2024-07-26
-$1.00M
10-Q · filed 2024-07-26
2024-03-31$0.00
10-Q · filed 2025-04-24
2023-09-30-$1.00M
10-Q · filed 2024-10-31
-$1.00M
10-Q · filed 2024-10-31
2023-03-31$0.00
10-Q · filed 2024-04-25
$0.00
derived: sum of 2 quarters · filed 2024-04-25
$0.00
derived: sum of 3 quarters · filed 2024-04-25
$1.00M
derived: sum of 4 quarters · filed 2024-04-25
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
$0.00
derived: sum of 2 quarters · filed 2023-10-26
$1.00M
derived: sum of 3 quarters · filed 2023-10-26
$0.00
10-K · filed 2023-02-14
2022-09-30$0.00
10-Q · filed 2023-10-26
$1.00M
derived: sum of 2 quarters · filed 2023-10-26
$0.00
10-Q · filed 2023-10-26
$0.00
derived: sum of 4 quarters · filed 2023-10-26
2022-06-30$1.00M
10-Q · filed 2023-07-27
$0.00
10-Q · filed 2023-07-27
$0.00
derived: sum of 3 quarters · filed 2023-07-27
$0.00
derived: sum of 4 quarters · filed 2023-07-27
2022-03-31-$1.00M
10-Q · filed 2023-04-27
-$1.00M
derived: sum of 2 quarters · filed 2023-04-27
-$1.00M
derived: sum of 3 quarters · filed 2023-04-27
-$2.00M
derived: sum of 4 quarters · filed 2023-04-27
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
$0.00
derived: sum of 2 quarters · filed 2023-02-14
-$1.00M
derived: sum of 3 quarters · filed 2023-02-14
-$2.00M
10-K · filed 2023-02-14
2021-09-30$0.00
10-Q · filed 2022-10-26
-$1.00M
derived: sum of 2 quarters · filed 2022-10-26
-$2.00M
10-Q · filed 2022-10-26
-$3.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30-$1.00M
10-Q · filed 2022-07-27
-$2.00M
10-Q · filed 2022-07-27
-$3.00M
derived: sum of 3 quarters · filed 2023-02-14
-$5.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31-$1.00M
10-Q · filed 2022-04-29
-$2.00M
derived: sum of 2 quarters · filed 2023-02-14
-$4.00M
derived: sum of 3 quarters · filed 2023-02-14
-$1.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
-$3.00M
derived: sum of 2 quarters · filed 2023-02-14
$0.00
derived: sum of 3 quarters · filed 2023-02-14
$1.00M
10-K · filed 2023-02-14
2020-09-30-$2.00M
10-Q · filed 2021-10-27
$1.00M
derived: sum of 2 quarters · filed 2021-10-27
$2.00M
10-Q · filed 2021-10-27
$9.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-06-30$3.00M
10-Q · filed 2021-07-28
$4.00M
10-Q · filed 2021-07-28
$11.00M
derived: sum of 3 quarters · filed 2022-02-09
$13.00M
derived: sum of 4 quarters · filed 2022-02-09
2020-03-31$1.00M
10-Q · filed 2021-04-29
$8.00M
derived: sum of 2 quarters · filed 2022-02-09
$10.00M
derived: sum of 3 quarters · filed 2022-02-09
$10.00M
derived: sum of 4 quarters · filed 2022-02-09
2019-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
$9.00M
derived: sum of 2 quarters · filed 2022-02-09
$9.00M
derived: sum of 3 quarters · filed 2022-02-09
$9.00M
10-K · filed 2022-02-09
2019-09-30$2.00M
10-Q · filed 2020-11-05
$2.00M
derived: sum of 2 quarters · filed 2020-11-05
$2.00M
10-Q · filed 2020-11-05
$2.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-06-30$0.00
10-Q · filed 2020-08-06
$0.00
10-Q · filed 2020-08-06
$0.00
derived: sum of 3 quarters · filed 2021-02-10
$2.00M
derived: sum of 4 quarters · filed 2021-02-10
2019-03-31$0.00
10-Q · filed 2020-05-07
$0.00
derived: sum of 2 quarters · filed 2021-02-10
$2.00M
derived: sum of 3 quarters · filed 2021-02-10
$1.00M
derived: sum of 4 quarters · filed 2021-02-10
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10
$2.00M
derived: sum of 2 quarters · filed 2021-02-10
$1.00M
derived: sum of 3 quarters · filed 2021-02-10
-$5.00M
10-K · filed 2021-02-10
2018-09-30$2.00M
10-Q · filed 2019-10-31
-$2.00M
10-Q · filed 2018-10-25
$1.00M
derived: sum of 2 quarters · filed 2019-10-31
-$5.00M
10-Q · filed 2019-10-31
$5.00M
10-Q · filed 2018-10-25
-$6.00M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
-$7.00M
10-Q · filed 2019-07-25
-$8.00M
derived: sum of 3 quarters · filed 2020-02-24
-$13.00M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31-$6.00M
10-Q · filed 2019-04-25
-$7.00M
derived: sum of 2 quarters · filed 2020-02-24
-$12.00M
derived: sum of 3 quarters · filed 2020-02-24
-$11.00M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
-$6.00M
derived: sum of 2 quarters · filed 2020-02-24
-$5.00M
derived: sum of 3 quarters · filed 2020-02-24
-$8.00M
10-K · filed 2020-02-24
$8.00M
10-K · filed 2018-02-13
2017-09-30-$5.00M
10-Q · filed 2018-10-25
-$4.00M
derived: sum of 2 quarters · filed 2018-10-25
-$7.00M
10-Q · filed 2018-10-25
$7.00M
derived: sum of 4 quarters · filed 2019-02-25
2017-06-30$1.00M
10-Q · filed 2017-07-27
-$2.00M
10-Q · filed 2017-07-27
$12.00M
derived: sum of 3 quarters · filed 2019-02-25
$16.00M
derived: sum of 4 quarters · filed 2019-02-25
2017-03-31-$3.00M
10-Q · filed 2017-04-27
$11.00M
derived: sum of 2 quarters · filed 2019-02-25
$15.00M
derived: sum of 3 quarters · filed 2019-02-25
$12.00M
derived: sum of 4 quarters · filed 2019-02-25
2016-12-31$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
$18.00M
derived: sum of 2 quarters · filed 2019-02-25
$15.00M
derived: sum of 3 quarters · filed 2019-02-25
$1.00M
10-K · filed 2019-02-25
-$1.00M
10-K · filed 2018-02-13
2016-09-30$4.00M
10-Q · filed 2017-10-26
$1.00M
derived: sum of 2 quarters · filed 2017-10-26
-$13.00M
10-Q · filed 2017-10-26
-$8.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-30-$3.00M
10-Q · filed 2017-07-27
-$17.00M
10-Q · filed 2017-07-27
-$12.00M
derived: sum of 3 quarters · filed 2018-02-13
-$4.00M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-31-$14.00M
10-Q · filed 2017-04-27
-$9.00M
derived: sum of 2 quarters · filed 2018-02-13
-$1.00M
derived: sum of 3 quarters · filed 2018-02-13
$8.00M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$13.00M
derived: sum of 2 quarters · filed 2018-02-13
$22.00M
derived: sum of 3 quarters · filed 2018-02-13
$14.00M
10-K · filed 2018-02-13
2015-09-30$8.00M
10-Q · filed 2016-10-27
$17.00M
derived: sum of 2 quarters · filed 2016-10-27
$9.00M
10-Q · filed 2016-10-27
2015-06-30$9.00M
10-Q · filed 2016-07-28
$1.00M
10-Q · filed 2016-07-28
2015-03-31-$8.00M
10-Q · filed 2016-04-28
2014-12-31-$6.00M
10-K · filed 2016-02-12
2014-09-30$13.00M
10-Q · filed 2015-10-27
$2.00M
derived: sum of 2 quarters · filed 2015-10-27
$0.00
derived: sum of 3 quarters · filed 2015-10-27
-$2.00M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-30-$11.00M
10-Q · filed 2015-07-23
-$13.00M
10-Q · filed 2015-07-23
-$15.00M
derived: sum of 3 quarters · filed 2016-02-12
-$20.00M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-31-$2.00M
10-Q · filed 2015-04-28
-$4.00M
derived: sum of 2 quarters · filed 2016-02-12
-$9.00M
derived: sum of 3 quarters · filed 2016-02-12
$3.00M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-31-$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
-$7.00M
derived: sum of 2 quarters · filed 2016-02-12
$5.00M
derived: sum of 3 quarters · filed 2016-02-12
$6.00M
10-K · filed 2016-02-12
2013-09-30-$5.00M
10-Q · filed 2014-10-24
$7.00M
derived: sum of 2 quarters · filed 2014-10-24
$8.00M
10-Q · filed 2014-10-24
-$8.00M
derived: sum of 4 quarters · filed 2015-02-13
2013-06-30$12.00M
10-Q · filed 2014-07-24
$13.00M
10-Q · filed 2014-07-24
-$3.00M
derived: sum of 3 quarters · filed 2015-02-13
$6.00M
derived: sum of 4 quarters · filed 2015-02-13
2013-03-31$1.00M
10-Q · filed 2014-04-29
-$15.00M
derived: sum of 2 quarters · filed 2015-02-13
-$6.00M
derived: sum of 3 quarters · filed 2015-02-13
-$12.00M
derived: sum of 4 quarters · filed 2015-02-13
2012-12-31-$16.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13
-$7.00M
derived: sum of 2 quarters · filed 2015-02-13
-$13.00M
derived: sum of 3 quarters · filed 2015-02-13
-$6.00M
10-K · filed 2015-02-13
2012-09-30$9.00M
10-Q · filed 2013-10-23
$3.00M
derived: sum of 2 quarters · filed 2013-10-23
$10.00M
10-Q · filed 2013-10-23
$8.00M
10-Q · filed 2012-10-24
$1.00M
derived: sum of 4 quarters · filed 2014-02-14
2012-06-30-$6.00M
10-Q · filed 2013-07-25
$1.00M
10-Q · filed 2013-07-25
-$8.00M
derived: sum of 3 quarters · filed 2014-02-14
-$11.00M
derived: sum of 4 quarters · filed 2014-02-14
2012-03-31-$1.00M
10-Q · filed 2013-04-25
-$2.00M
derived: sum of 2 quarters · filed 2014-02-14
-$5.00M
derived: sum of 3 quarters · filed 2014-02-14
2011-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14
-$4.00M
derived: sum of 2 quarters · filed 2014-02-14
-$7.00M
10-K · filed 2014-02-14
2011-09-30-$3.00M
10-Q · filed 2012-10-24
-$6.00M
10-Q · filed 2012-10-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
PFIZER INC (PFE)United States$162.042B31.94
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64